Table 2 Comparison of clinical and laboratory parameters of participants according to BDNF Val66Met genotypes
|  | Val–Met/Met–Met n = 280 | Val–Val n = 354 | P value |
|---|---|---|---|
CRP (mg/L) | 2.06 ± 1.54 | 2.41 ± 1.46 | 0.4ª |
PTX3 (ng/ml) | 2.61 ± 0.51 | 2.65 ± 0.49 | 0.6ª |
IL-18 (ng/ml) | 250.19 ± 29.6 | 246.55 ± 27.2 | 0.4ª |
TAC (g/dl) | 2.55 ± 0.58 | 2.46 ± 0.57 | 0.6ª |
SOD (U/ml) | 0.14 ± 0.04 | 0.14 ± 0.04 | 0.7ª |
PG2A (ng/ml) | 71.23 ± 5.74 | 73.48 ± 6.67 | 0.2ª |
Leptin (ng/ml) | 26.32 ± 16.18 | 24.52 ± 13.19 | 0.008 |
Ghrelin (ng/ml) | 2.27 ± 1.14 | 2.54 ± 1.50 | 0.02 |
TG (mg/dl) | 173.1 ± 90.98 | 178.8 ± 93.77 | 0.8 |
TCH (mg/dl) | 192.21 ± 59.28 | 196.36 ± 63.45 | 0.3 |
LDL-C (mg/dl) | 106.27 ± 34.69 | 107.26 ± 32.74 | 0.5 |
HDL-C (mg/dl) | 52.21 ± 12.30 | 53.68 ± 11.78 | 0.5 |
LDL/HDL | 2.08 ± 0.67 | 3.06 ± 13.34 | 0.05 |